Country Manager - DACH

Company

hirify.global is a global diagnostics company transforming cancer care with high-value genomic and clinical insights.

What you will do

• Lead commercial strategy for the DACH region: territory-specific go-to-market, channel plans, and public reimbursement/guideline inclusion.
• Drive PROSIGNA™ adoption via targeted marketing activities and participation in key oncology congresses and seminars.
• Own territory performance: set account goals, track progress, resolve issues, and manage recruitment/headcount planning aligned with budgets.
• Manage market access activities with health authorities, including pricing, reimbursement pathways, and professional relationship building.
• Oversee territory operations and administrative/financial/strategic planning functions, including operational management of the product portfolio.
• Lead tender management and business development efforts, including market analysis, opportunity assessment, and alignment with portfolio strategy.

Requirements

• Over 8 years of commercial leadership experience with full revenue and P/L responsibility.
• Proven track record launching oncology drugs and/or diagnostics, ideally in lean, fast-paced organizations.
• Experience establishing reimbursement pathways and strong knowledge of health economics and the diagnostic market landscape.
• Demonstrated success negotiating and closing deals with hospitals and health authorities, including tender management.
• Strong influencing and communication skills with senior thought leaders, clinicians/KOLs, payers, regulators, and internal stakeholders.
• Strong leadership capabilities with experience collaborating with international headquarters and cross-functional teams.

Culture & Benefits

• Purpose-driven environment focused on transforming cancer care and supporting clinicians’ decision-making.
• Values-led culture emphasizing bold ideas, execution with excellence, teamwork, and integrity.
• Competitive compensation and benefits.
• Inclusive workplace with recognition as a Great Place to Work in the US and Israel (2024).